{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:35Z","timestamp":1793701355117,"version":"4.5.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI137681"],"award-info":[{"award-number":["R01 AI137681"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["103420\/Z\/13\/Z"],"award-info":[{"award-number":["103420\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","award":["BHPG13-2"],"award-info":[{"award-number":["BHPG13-2"]}],"id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI118626"],"award-info":[{"award-number":["U19 AI118626"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.tube.2021.102127","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T11:50:41Z","timestamp":1631620241000},"page":"102127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1692-2758","authenticated-orcid":false,"given":"Julie G.","family":"Burel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6941-3618","authenticated-orcid":false,"given":"Akul","family":"Singhania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Dubelko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-1302","authenticated-orcid":false,"given":"Eneida","family":"Parizotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dedicoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam F.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-8002","authenticated-orcid":false,"given":"Cecilia S.","family":"Lindestam Arlehamn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-0574","authenticated-orcid":false,"given":"Donald G.","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2779-3197","authenticated-orcid":false,"given":"Timothy","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-6693","authenticated-orcid":false,"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2021.102127_bib1","series-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.tube.2021.102127_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2021.102127_bib3","doi-asserted-by":"crossref","first-page":"14480","DOI":"10.1038\/s41598-018-32755-x","article-title":"Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection","volume":"8","author":"O'Shea","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2021.102127_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2021.102127_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a Re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2021.102127_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tube.2021.102127_bib7","series-title":"Latent TB infection testing and treatment programme: technical guidance and specification","author":"England","year":"2019"},{"key":"10.1016\/j.tube.2021.102127_bib8","author":"World Health Organization"},{"key":"10.1016\/j.tube.2021.102127_bib9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2021.102127_bib10","first-page":"CD007545","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","author":"Sharma","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tube.2021.102127_bib11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","volume":"30","author":"Sterling","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.tube.2021.102127_bib12","first-page":"e23","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. Reply","volume":"381","author":"Chaisson","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2021.102127_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2021.102127_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1378\/chest.13-1232","article-title":"Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study","volume":"145","author":"Johnson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.tube.2021.102127_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2021.102127_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fimmu.2019.00221","article-title":"Host transcriptomics as a tool to identify diagnostic and mechanistic immune signatures of tuberculosis","volume":"10","author":"Burel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2021.102127_bib17","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"Acs, groups GCcs. A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2021.102127_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(16)00048-5","article-title":"Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis","volume":"4","author":"Sweeney","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2021.102127_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3779","article-title":"Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response","volume":"1","author":"Warsinske","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tube.2021.102127_bib20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/cid\/ciz252","article-title":"Blood transcriptomic stratification of short-term risk in contacts of tuberculosis","volume":"70","author":"Roe","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2021.102127_bib21","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1038\/s41598-020-65043-8","article-title":"Adolescent cohort study t, consortium GC, clinical S, laboratory T, screen TBC, consortium A-T, Re PBT, Peruvian household contacts cohort T, team CI. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response","volume":"10","author":"Penn-Nicholson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2021.102127_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(19)30282-6","article-title":"Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis","volume":"8","author":"Gupta","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2021.102127_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046191","article-title":"Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy","volume":"7","author":"Bloom","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102127_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2021.102127_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/infdis\/jiv447","article-title":"Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment","volume":"213","author":"Cliff","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2021.102127_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","article-title":"Catalysis TBBC. Host blood RNA signatures predict the outcome of tuberculosis treatment","volume":"107","author":"Thompson","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2021.102127_bib27","article-title":"Transcriptomic profiles of confirmed pediatric tuberculosis patients and household contacts identifies active tuberculosis, infection, and treatment response among Indian children","author":"Tornheim","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2021.102127_bib28","doi-asserted-by":"crossref","first-page":"102033","DOI":"10.1016\/j.tube.2020.102033","article-title":"Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals","volume":"127","author":"Broderick","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2021.102127_bib30","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/bioinformatics\/btm311","article-title":"beadarray: R classes and methods for Illumina bead-based data","volume":"23","author":"Dunning","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tube.2021.102127_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"lumi: a pipeline for processing Illumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tube.2021.102127_bib32","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tube.2021.102127_bib33","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tube.2021.102127_bib34","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","article-title":"Impact of genetic polymorphisms on human immune cell gene expression","volume":"175","author":"Schmiedel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tube.2021.102127_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.tube.2021.102127_bib36","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tube.2021.102127_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fphar.2019.00445","article-title":"The NCATS BioPlanet - an integrated platform for exploring the universe of cellular signaling pathways for toxicology, systems biology, and chemical genomics","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tube.2021.102127_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171358","article-title":"Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages","volume":"12","author":"La Manna","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102127_bib39","doi-asserted-by":"crossref","first-page":"3270393","DOI":"10.1155\/2019\/3270393","article-title":"Value of the ratio of monocytes to lymphocytes for monitoring tuberculosis therapy","volume":"2019","author":"Wang","year":"2019","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.tube.2021.102127_bib40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tube.2021.102127_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001538","article-title":"Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study","volume":"10","author":"Kaforou","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2021.102127_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1473-3099(20)30914-2","article-title":"Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial","volume":"21","author":"Scriba","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2021.102127_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/gene.2010.51","article-title":"Human gene expression profiles of susceptibility and resistance in tuberculosis","volume":"12","author":"Maertzdorf","year":"2011","journal-title":"Gene Immun"},{"key":"10.1016\/j.tube.2021.102127_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41590-018-0111-5","article-title":"Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza","volume":"19","author":"Dunning","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tube.2021.102127_bib45","first-page":"5","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.tube.2021.102127_bib46","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.tube.2021.102127_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12916-014-0120-7","article-title":"The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life","volume":"12","author":"Naranbhai","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.tube.2021.102127_bib48","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1183\/13993003.00263-2015","article-title":"Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study","volume":"46","author":"Rakotosamimanana","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2021.102127_bib49","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/mi.2016.105","article-title":"IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis","volume":"10","author":"Venkatasubramanian","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.tube.2021.102127_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","article-title":"A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes","volume":"560","author":"Roy Chowdhury","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tube.2021.102127_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2018.00257","article-title":"Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease","volume":"9","author":"Garand","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2021.102127_bib52","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2666-5247(21)00043-4","article-title":"Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study","volume":"2","author":"Belay","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.tube.2021.102127_bib53","doi-asserted-by":"crossref","first-page":"1297131","DOI":"10.1155\/2019\/1297131","article-title":"Expression of USP18 and IL2RA is increased in individuals receiving latent tuberculosis treatment with isoniazid","volume":"2019","author":"de Oyarzabal","year":"2019","journal-title":"J Immunol Res"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979221000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979221000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:45:10Z","timestamp":1761468310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979221000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":52,"alternative-id":["S1472979221000779"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2021.102127","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2021.102127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102127"}}